Sermorelin
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
Top View
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act
- 32-2025: GHRH Description Product Info Application Note
- Ibm Micromedex® Carenotes Titles by Category
- WO 2017/060500 Al 13 April 2017 (13.04.2017) P O P C T
- Sermorelin Acetate (Growth Hormone Releasing Hormone /Peptide) Therapy
- Appln. Id 81062/98 Pct Number Pct/Ep98/03079 Wo 98/53844
- (12) Patent Application Publication (10) Pub. No.: US 2004/0142870 A1 Finn (43) Pub
- Subject Index
- 4/23/2019 NDC/Ref. No. ITEM DESCRIPTION SIZE AWP 62991
- PHARMACOLOGY: Core Concepts and Learning Objectives
- Potency Price List
- Sermorelin Q and A’S
- Gpi Drug Classification Report
- Sermorelin in the Management of Age-Related Growth Hormone Insufficiency
- Sermorelin Patient Education Sheet
- Fall 2017 Digital Edition
- Tailor Made Compounding
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12